Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com.
|
|
|
1,001-5,000 employees
View all Cepheid employees
|
|
Biotechnology
|
|
904 Caribbean Drive, Sunnyvale, CA 94089, US
|
|
1996
|
|
Genetic Testing, Cancer, Molecular Diagnostics, Pcr, Molecular Biology, Infectious Diseases
|
John Bishop is the CEO of Cepheid.
The decision makers in Cepheid are Andrew Walker, Annamaria Vaszko, Brian Sarina, etc. Click to Find Cepheid decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.